Judi Health key facts
as of Oct 2026- Developer of a pharmacy benefit management platform designed for cost-effective prescription drug coverage.
- Judi Health is valued at approximately $3.3B as of Oct 2026 (last reported valuation).
- It has raised $762.0M; the latest was Later Stage VC ($400.0M) in Sep 2025.
- Notable investors include Alumni Ventures, General Catalyst, F-Prime Capital, B Capital Group, 9Yards Capital — 26 tracked in total.
- Status: Privately Held (backing).
Judi Health's last reported valuation, Sep 2025. Nothing priced has surfaced since.
- ·The complete investor list: 26 names
- ·Watch Judi Health: the Monday email on marks, rounds and moves
Judi Health funding rounds
No funding rounds for Judi Health are on record yet — either the company hasn't raised institutional capital, or the raise hasn't surfaced in our sources.
Who backs Judi Health
26+Judi Health valuation
Judi Health's last reported valuation was $3.3 billion in Sep 2025. No priced round, secondary trade or fund mark has surfaced since.
Judi Health investors
26 investors are on record for Judi Health, including Alumni Ventures, General Catalyst, F-Prime Capital and B Capital Group. By type, the record holds 8 venture capital firms and 2 asset managers.
About Judi Health
Developer of a pharmacy benefit management platform designed for cost-effective prescription drug coverage. The company's platform centralizes pharmacy benefit operations, integrating real-time claims processing, formulary management, and rebate transparency, enabling health plan administrators to streamline drug pricing, improve access to medications, and ensure regulatory compliance.
- Sector
- Healthcare
- HQ
- New York, NY, United States
- Founded
- 2017
- Employees
- 822
- Website
- judi.health/
- Ownership
- Privately Held (backing)
Is this your company? Sign in with your work email to keep it current, or tell us what's wrong.